Home
Conditions
Neoadjuvant Therapy

Clinical trial condition

Neoadjuvant Therapy

Explore clinical trials studying Neoadjuvant Therapy. Study availability and eligibility vary by location and protocol.

119 public trials 45 recruiting studies

Refine in advanced search Browse all conditions

Neoadjuvant Therapy trial results

Active, Not Recruiting

Serplulimab Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma

NCT05659251

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations: 2nd Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, China

View Trial Details

Active, Not Recruiting

Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer

NCT06124378

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +10 more
Locations: The First Affiliated Hospital of Guangxi Medical University Nanning, Guangxi, China

View Trial Details

Active, Not Recruiting

Application of Targeted Axillary Lymph Node Resection in Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: an Open-label, Multicenter Study

NCT07032220

Conditions: Breast Cancer Surgery, Neoadjuvant Therapy, Sentinel Lymph Node Biopsy (SLNB)
Locations: Study Officials Fuzhou, Fujian, China

View Trial Details

Active, Not Recruiting

Carrelizumab, Chemotherapy and Apatinib in the Neoadjuvant Treatment of Resectable Esophageal Squamous Cell Carcinoma

NCT04666090

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations: 2nd Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, China

View Trial Details

Active, Not Recruiting

Predictive Value of Tumor Vascular Normalization Scoring in HER-2 Positive Breast Cancer

NCT06868758

Conditions: HER2 Positive Breast Carcinoma, Neoadjuvant Therapy
Locations: Chongqing General Hospital Chongqing, Chongqing Municipality, China

View Trial Details

Active, Not Recruiting

Phase II Neoadjuvant Pyrotinib Combined with Neoadjuvant Chemotherapy in HER2-low-expressing and HR Positive Early or Locally Advanced Breast Cancer: a Single-arm, Non-randomized, Single-center, Open Label Trial

NCT05165225

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
Locations: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

Neoadjuvant Degarelix With or Without Apalutamide (ARN-509) Followed by Radical Prostatectomy

NCT03080116

Conditions: Androgen Antagonists, Genital Diseases, Genital Diseases, Male, +11 more
Locations: University Hospitals Leuven Leuven, Vlaams-brabant, Belgium

View Trial Details

Active, Not Recruiting

Neoadjuvant/Adjuvant Pembrolizumab Plus Chemotherapy

NCT05383716

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations: Peking Union Medical College Hospital Beijing, China

View Trial Details

Active, Not Recruiting

Reducing Excision Margins After Neoadjuvant Chemoimmunotherapy for HPV Negative Resectable Locally Advanced HNSCC

NCT05459415

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +10 more
Locations: Zhanjie Zhang Wuhan, Hubei, China

View Trial Details

Neoadjuvant Therapy

Neoadjuvant Therapy trial results

Related conditions